Royal Bank of Canada
INKT icon

Royal Bank of Canada’s MiNK Therapeutics INKT Stock Holding History

Royal Bank of Canada’s Portfolio INKT Stock Details INKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-16
Closed – – 7116
2024
Q2 		$0 Buy
16
+4
+33% +$39 ﹤0.01% 7277
2024
Q1 		$0 Sell
12
-53
-82% -$492 ﹤0.01% 7268
2023
Q4 		$1K Hold
65
– – ﹤0.01% 6938
2023
Q3 		$1K Buy
65
+11
+20% +$179 ﹤0.01% 6896
2023
Q2 		$1K Buy
54
+43
+391% +$862 ﹤0.01% 7016
2023
Q1 		$0 Sell
11
-12
-52% -$260 ﹤0.01% 7256
2022
Q4 		$1K Sell
23
-24
-51% -$563 ﹤0.01% 7041
2022
Q3 		$1K Buy
+47
New +$926 ﹤0.01% 7202
2022
Q2 		– Sell
-12
Closed – – 7527
2022
Q1 		$0 Sell
12
-37
-76% -$1.11K ﹤0.01% 7864
2021
Q4 		$2K Buy
+49
New +$5.83K ﹤0.01% 7406

Other funds holding INKT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LF
Longbow Finance Lutry, Switzerland $782M AUM 48.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Royal Bank of Canada's INKT Position: Q3 2024 in Review

Royal Bank of Canada sold out of MiNK Therapeutics (INKT) in Q3 2024, closing a stake of 16 shares.

Royal Bank of Canada first reported a position in INKT in Q4 2021 and held it in 10 quarters. The position peaked at $2K in Q4 2021. 24 funds tracked by Wall St. Rank hold INKT as of Q3 2024.

  • Royal Bank of Canada reported no remaining MiNK Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Royal Bank of Canada sold 16 MiNK Therapeutics shares in Q3 2024.
  • Royal Bank of Canada first reported a position in MiNK Therapeutics in Q4 2021 and held it in 10 quarters.
  • Royal Bank of Canada's MiNK Therapeutics position peaked at $2K in Q4 2021.
  • 24 funds tracked by Wall St. Rank held MiNK Therapeutics as of Q3 2024.

Based on Royal Bank of Canada's 13F filing for Q3 2024, filed 14 Nov 2024.